MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

BN82002 hydrochloride

CAS No. : 1049740-43-3

MCE 站：BN82002 hydrochloride

产品活性：BN82002 hydrochloride 是 CDC25 phosphatase 家族的有效，选择性和不可逆的泛抑制剂。 BN82002 hydrochloride抑制 CDC25A，CDC25B2，CDC25B3，CDC25C CDC25A 和 25C-cat 的 IC₅₀ 值分别为 2.4、3.9、6.3、5.4 和 4.6 µM。 BN82002 hydrochloride 显示出比 CD45 酪氨酸磷酸酶高约 20 倍的选择性。

研究领域：Metabolic Enzyme/Protease

作用靶点：Phosphatase

In Vitro: The effect of BN82002 on cell proliferation is evaluated in vitro on several human tumor cell lines. Menadione, which has been reported to inhibit cell proliferation, is used as a control. All of the examined cell lines are sensitive to BN82002 ａnd Menadione in a concentration-dependent manner in the low micromolar range. The most sensitive is the pancreatic cancer cell line MIA PaCa-2 with an IC₅₀ of 7.2 μM, ａnd the less sensitive cell line is the colon cancer HT-29 with an IC₅₀ of 32.6 μM. The range of activity is very similar to the one observed with menadione (5-15 μM). It is also showed that 50 μM BN82002 is a concentration that fully inhibits cell proliferation, the cell cycle distribution is only modestly affected with a slight decrease in S phase ａnd an increase in cells containing both a G1 ａnd a G2 DNA content, suggesting that the cells treated with BN82002 are arrested at various stages of the cell cycle.

相关产品：Cyclosporin A  |  Tacrolimus  |  SHP099  |  Ebselen  |  Salubrinal  |  Calyculin A  |  Suramin sodium salt  |  TNO155  |  RMC-4550  |  β-Glycerophosphate disodium salt pentahydrate  |  Sodium orthovanadate  |  DT-061  |  TPI-1  |  Okadaic acid  |  GSK 2830371  |  MSI-1436 lactate  |  D-erythro-Sphingosine  |  NSC 663284  |  SF1670  |  Sodium metatungstate  |  BCI  |  Voclosporin  |  MB05032  |  SMAP-2  |  NSC-87877  |  Sal003  |  Sodium stibogluconate  |  3α-Aminocholestane

品牌介绍:
•   MCE (MedChemExpress) 拥有数百种全球独家化合物，我们致力于为全球科研客户提供*新*全的高品质小分子活性化合物；
•   10,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领域；
•   设有专业的实验中心和严格的质控、验证体系；
•   提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告，确保产品的高纯度、高品质；
•   产品的生物活性多经各国客户实验验证；
•   Nature, Cell, Science 等多种期刊及制药收录了MCE客户的科研成果；
•   专业团队跟踪*新的制药及生命科学研究进展，为您提供全球*新的活性化合物；
•   与世界各大制药公司及知名科研机构建立了长期的合作。